NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)
National Institutes of Health
Free. Verify your email, then we send one reminder only.
- Posted
- Oct 23, 2025
- Closes
- May 25, 2029 (in 1030 days)
Similar opportunities open now
- NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses May 2029
- NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)OpenNational Institutes of HealthCloses Jul 2029
- NIH Director’s New Innovator Award (DP2 Clinical Trial Optional)OpenNational Institutes of HealthCloses in 18 daysUp to $475K
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)OpenNational Institutes of HealthCloses Jan 2027Up to $500K
- NHLBI Program Project Applications (P01 Clinical Trials Optional)OpenNational Institutes of HealthCloses in 57 days
Classification and identifiers
- Solicitation number
- PAR-27-082
- Assistance listing (CFDA)
- 93.855
Amount
Amount not published by the funder
Who can apply
Public colleges and universities and State government agencies can all apply here. Check the eligibility details below to see if your organization fits.
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
About this opportunity
This notice of funding opportunity (NOFO) invites submission of investigator-initiated Program Project (P01) applications. The proposed Programs should address scientific areas relevant to the NIAID mission including: biology and pathogenesis of infectious microbes, including HIV; host-microbe interactions; mechanisms regulating immune system development and function across the lifespan, and in response to infectious pathogens; immune dysfunction resulting in allergy, asthma, autoimmunity, immunodeficiency, or transplant rejection; and translational research to develop vaccines, therapeutics, and diagnostics to prevent and treat infectious and immune-mediated diseases. Each application submitted to this NOFO must include at least two related, synergistic Research Projects that share a comm...
Related opportunities
- NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)National Institutes of HealthCloses May 2029
- NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)National Institutes of HealthCloses Jul 2029
- NIH Director’s New Innovator Award (DP2 Clinical Trial Optional)National Institutes of HealthCloses in 18 daysUp to $475K
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)National Institutes of HealthCloses Jan 2027Up to $500K
- NHLBI Program Project Applications (P01 Clinical Trials Optional)National Institutes of HealthCloses in 57 days
- NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)National Institutes of HealthCloses Apr 2029